Introduction
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) as well as the related animal virus, simian immunodeficiency virus (SIV) encode not only the retroviral gag, pol and env genes but also additional genes which include the regulatory genes (tat and rev) and accessory genes (v/f, vpu, vpr, vpx, vpr and neffor HIV-2 and SIV). These accessory genes are designated 'non-essential' because they are dispensable for viral replication in some in vitro tissue culture systems (Subbramanian & Cohen, 1994) . However, the conservation of these genes in different viral isolates suggests a fundamental role in vivo (i.e., infection of the susceptible host).
The HIV-1 v/f(virion infectivity factor) gene encodes a 23 kDa protein (Kan et al., 1986; Lee et al., 1986 ) which is a late gene product whose expression is Rev dependent (Garrett et al., 1991; Schwartz et al., 1991) .
The v/f gene is highly conserved among different HIV isolates and is present in all members of the lentivirus group with the exception of equine infectious anaemia virus (Oberste & Gonda, 1992) . Initial studies have shown that vlf-defective HIV-1 genomes introduced into * Author for correspondence. Fax + 1 916 752 4548. permissive cells by transfection are transcribed and translated, and virions are released to a level comparable to cells transfected with the wild-type viral genome (Strebel et al., 1987; Sakai et al., 1993) . However, vtfdefective cell-free virions are 100-1000-fold less infectious (Fisher et al., 1987; Strebel et al., 1987) . The decrease in infectivity of v/f-defective HIV-1 particles is cell-type specific (Gabuzda et al., 1992) . Studies on HIV-1 have indicated that v/f mutant viruses derived from the T cell line CEM-SS are severely impaired in their ability to complete proviral DNA synthesis in non-permissive cells (Von Schwedler et al., 1993) . The goal of this study was to analyse the role of Vif in SIV replication in T cell lines as well as primary lymphoid cells.
Methods
Construction t~f vif mutations in SIVmac239. All mutations were introduced into the proviral clone pMA239 (Fig. 1 ) provided by Dr A. Adachi (University of Tokyo). The SIVmac239Avtf mutant was constructed by deleting nucleotides between the BglII site at 5698 and the ScaI site at 5845. A plasmid subclone containing a DNA fragment from the XbaI site at 4986 to the SacI at 6016 was first digested with BglII, filled in with the Klenow fragment of DNA polymerase I, then ligated to the blunt end of a SeaI site. As a result, a Avtf construct containing a 147 bp deletion and a translational frame shift within the Vif coding region was generated. To determine the significance of Vif domains on function, two additional v/f mutants were produced. The SIVmac239-2S vzf mutant was constructed by introducing two consecutive stop codons to the N terminus at nucleotide (nt) 5670 by polymerase chain reaction (PCR). The S1Vmac239-2C v(fmutant was 
SIVmac239-vif2C
6dl 0 constructed by introducing two consecutive stop codons near the C terminus at nt 6010 using oligonucleotides. Briefly, a plasmid subclone, containing a DNA fragment from the XbaI site at nt 4986 to the SacI at nt 6016 was digested with AvaI at nt 6007 and SacI at nt 6016 and replaced with oligonucleotides containing two consecutive stop codons; this mutant is truncated by 228 bp in the v/fgene. All mutations were confirmed by DNA sequencing. Because wild-type SIVmac239 does not replicate efficiently in H9 cells due to the full-length transmembrane domain of env (Kodama et al., 1989; Johnston et al., 1993) , chimeras of SIVmac239 wt and SlVmac239Av/fwith the HIV-ls~33 env gene were constructed. Briefly, the 5' portion of pMA239 from the EcoRI site in the cellular flanking sequence to the SphI site at nt 6707 was ligated to a DNA fragment of pSHIV-33/3' (from SphI site to EcoRI site; Luciw et al., 1995) containing the env gene of HIV-ls~,33 (York-Higgins et al., 1990) .
Cells. The CEMx174 cell line is a human hybrid T/B cell line provided by J. Hoxie (University of Pennsylvania). CEM-SS, SupT1 and H9 T lymphoid cell lines were obtained from the AIDS Research and Reference Program, National Institutes of Health (Bethesda, Maryland). All T cell lines were maintained in RPMI medium supplemented with 10 % heat-inactivated (56 °C for 30 rain) fetal calf serum (FCS) and antibiotics (100 lag/ml penicillin and 100 lag/ml streptomycin). Because SIVmac239 replicates well in human peripheral blood mononuclear cells (huPBMC), these cells were used as the source of primary T lymphocytes. Importantly, huPBMC show prolonged growth in complete RPMI medium supplemented with human interleukin-2 (IL-2) compared to rhesus monkey PBMC. Human PBMCs were obtained from healthy seronegative blood donors (provided by Irwin Memorial Blood Bank, San Francisco, California), stimulated with phytohaemagglutinin (3 lag/ml), and maintained in RPMI1640 medium supplemented with 10% FCS and 10% interleukin-2 (Collaborative Research) and antibiotics. Rhesus PBMCs obtained from two healthy, seronegative macaques (#23803 and #25874) were stimulated and maintained in the same way as for the human PBMCs.
Tramfections. Cell-free wild-type and v/f-defective viruses were prepared by transfecting SupT1, CEM-SS and H9 cells with 5 lag of wild-type and v/f-defective proviral plasmid by the electroporation method (200 V and 960 laF (RT) assay (Willey et al., 1988) . Superuatants harvested at the peak of RT activity were used for infections of CEMx174 cells, huPBMC and rhesus macaque PBMC.
Preparation of virus stocks. The viral supernatants harvested at the peak of RT activity were filtered through 0.45 gm filter and frozen in aliquots. The TCIDs0 of these virus stocks were determined in CEMx174 cells in microtitre plates. Titres were calculated by the method of Reed & Muench (Burleson et al., 1992) . For the analysis of viral DNA synthesis in infected cells, 2 x 105 huPBMC were infected with viruses at an m.o.i, of 0.05. Equal amounts of RT of cell-free wild-type and mutant viruses were treated with 500 U/ml of RNase-free DNase (Boehringer Mannheim Biochemica) in the presence of 10mM-MgC12 for 1 h at 37 °C. Heatinactivated virus controls were prepared by incubating wild-type virus at 56 °C for 1 h before treatment with DNase. Infected cells were removed at different time points, washed three times with PBS, pelleted and resuspended with 80 gl of lysis buffer (10 mM-Tris-HC1 pH 8.3, 0.45 % NP40, 0.45 % Tween 20 and 50 gg/ml proteinase K). The cell suspensions were incubated at 56 °C for 3 h. Proteinase K was inactivated by boiling these lysates for 10 min.
Infection of cells. For
Polymerase chain reaction (PCR) analysis. To compare the amounts of viral DNA synthesized by vtf mutants and wild-type virus in huPBMC for a single round of viral replication, lysates of infected huPBMC taken within 48 h post-infection (p.i.) were subjected to PCR amplification using primers that flank the primer binding site (PBS) of SIVmac239. Primer SIV265 5' AGTCGCTCTGCGGAGAGGCTGG 3' specific to R region (nt 774-796) and the primer SIV267 5 / GATTTTCCTGCTTCGGTTTCCC 3' specific to the leader sequence (nt 1228-1249) employed for PCR reactions detect only full-length or nearly complete proviral DNA (Zack et al., 1990) . Primer SIV265 was 32P-end-labelled and 20 pmol of each primer was used for the PCR reaction. An oligonucleotide pair complementary to the first exon of the human fl-globin gene (Lawn et al., 1980) was included in each reaction as an internal standard for the amount of DNA present in the PCR amplifications. PCR was carried out in 50 pl reaction mixture containing 0-125 mM final concentration of each of the four deoxynucleoside triphosphates0 50 mM-KC1, 10 mg-Tris-HCl pH 8-3, 1.5 mM-MgCI2, 2 U Taq DNA polymerase (Perkin Elmer) and 20 gl of cell lysate. The reaction mixtures were overlaid with 50 gl of mineral oil and subjected to denaturation at 94 °C for 2 min in a Perkin Elmer Cetus thermocycler, followed by 30 cycles of amplification with denaturation at 94 °C for 1.5 min, annealing and polymerization at 72 °C for 3 min and a final 7 min extension at 72 °C. Amplified products were analysed by electrophoresis on 5% non-denaturing polyacrylamide gels and visualized by autoradiography of the dried gels.
Results

Vif is dispensable for replication of SIVmac239 in SupT1 and CEM-SS cells
The effect of vlfon SIVmac239 replication in T cells was examined by transfecting equal amounts of either vzfpositive or vlf-negative viral DNA (Fig. 1) into SupT1 and CEM-SS human T lymphocyte cell lines. Virus replication was monitored by measuring the level of RT activity in the culture supernatants. Both SupT1 and CEM-SS cell lines supported replication of all three v~fdefective mutants of SIVmac239 to a level comparable to the parental vtf-positive virus ( Fig. 2a, b) . Thus, these cell lines may contain a factor(s) that complements for the Vif defect in SIVmac or lack an inhibitor of virus growth, normally counterbalanced by Vif.
Vif is required for replication of SIVmac239 in H9 cells'
SIVmac239 does not replicate efficiently in some human T cell lines including H9 due to the full-length transmembrane domain of the envelope glycoprotein (Kodama et al., 1989; Johnston et aI., 1993) . To assess the ability of vzf-negative SIVmac239 viral DNA to replicate in H9 cells, SIV/HIV-1 (SHIV) chimeric viruses were generated. SHIVsFa3 has tat, rev and env gpl60 of HIV-lsF33 and all other genes of SIVmac239 (Luciw et al., 1995) . The deletion form of SIVmac239 v/f (Fig. 1) was used to substitute for the full-length SIVmac239 v/f gene in SHIVsFa~; this vtfdeletion viral DNA plasmid is designated SHIVsF33Av~ No RT activity was detected in H9 cells transfected with SIVmac239Avzf viral DNA plasmid (Fig. 3 a) or chimeric SHIVsF33Avl f viral DNA plasmid (Fig. 3b) , although the parental virus SIVmac239 (Fig. 3 a) or SHIVsraa (Fig. 3 b) replicated well. Thus, Vif is required for SIVmac239 replication in H9 cells. A delay in SIVmac239 replication was observed in H9 cells during the early period (Fig. 3 a) . Presumably, a variant virus with premature stop codon in the gp41 gene is produced during this period of infection.
Vif is required for infection of SIVmac239 in primary T lymphocytes as cell-free virus
The requirement for Vif for the establishment of infection in primary lymphocytes with cell-free virus was examined by infecting primary cultures of huPBMC and rhesus macaque PBMC with equivalent amounts of vzf-positive and vtf-negative virus stocks prepared from transfected SupT1 or CEM-SS cell lines. For this experiment, the permissive CEMx 174 cell line served as a positive control for replication of mutant and wild-type viruses. Both v/f- Lane 1 is the same as lane 2 in (a).
positive and v/f-negative viruses established productive infection in CEMx174 cells (Fig. 4) . However, v/fdefective viruses failed to replicate in primary h u P B M C and rhesus P B M C cultures; the wild-type SIVmac239 control replicated in these p r i m a r y T lymphocytes (Fig.  4) . These findings, d e m o n s t r a t i n g the requirement for Vif in p r i m a r y cells, suggest that Vif plays an i m p o r t a n t role in viral replication in vivo.
Proviral D N A synthesis by vif mutants after entry into target cells'
Because Analysis of D N A from cells exposed to heat-inactivated virus demonstrates very little, if any, detectable proviral D N A (Fig. 5 a, b) . Similar a m o u n t s of proviral D N A were observed from 6-27 h p.i. in h u P B M C infected with either v/f-positive or v/f-negative viruses (Fig. 5) . This finding shows that v/f-defective viruses p r o d u c e d from SupT1 (Fig. 5a) and C E M -S S (Fig. 5b) cells are able to complete the first r o u n d o f p r o v i r a l D N A synthesis in non-permissive p r i m a r y T lymphocyte cultures.
D i s c u s s i o n
The aim of this study was to analyse the role of v/f in S I V m a c replication. O u r results demonstrate that the requirement for v/f is cell-type specific, as has been observed for HIV-1 ( G a b u z d a et al., 1992) and SIV (Gibbs et al., 1994; P a r k et al., 1994) . H9 cells do not s u p p o r t replication of v/f-defective SIVmac239. How-On: Thu, 27 Dec 2018 08:21:36 ever, both SupT1 and CEM-SS cell lines are permissive for vlf-defective SIVmac239. This could be due to the presence of compensatory cellular components in SupT1 and CEM-SS cells that complement for the function of Vif protein or the absence of an inhibitor of virus growth, which is normally counterbalanced by Vif. It has been suggested that Vif may play a role in viral protein processing, assembly or virus maturation. The study by Guy et al. (1991) suggests that HIV-1 Vif possesses a cysteine protease activity and is involved in the processing of the subunits of Env glycoprotein. Another report on HIV-1 demonstrated that the incorporation of envelope glycoprotein into viral particles is greatly impaired in the absence ofVif (Sakai et al., 1993) . Recent studies by Hoglund et al. (1994) showed that virions produced by v/f-defective HIV-1 genomes had an aberrant core; thus, Vif may play a role in the final stages of viral assembly.
Although SIVmac v/f-defective viruses did not produce infectious progeny viruses in primary T lymphocytes, these v/f mutants derived from SupT1 and CEM-SS were able to complete the first round of proviral DNA synthesis in a fashion similar to v/f-positive virus. The CEM-SS cell line is considered to be semi-permissive for HIV-1 Vif mutant and v/f-defective HIV-1 derived from CEM-SS does not complete proviral DNA synthesis in non-permissive cell lines (Von Schwedler et al., 1993) .
Our study also demonstrates that v/f is required for the establishment of SIVmac infection in peripheral blood T lymphocytes; v/f-defective viruses from transfected SupT1 and CEM-SS cells failed to establish infection in primary cultures of huPBMC and rhesus macaque PBMC which supported replication of wild-type SIVmac239 virus. Other investigators have also observed that deletion mutants of SIVmac239 were restricted for replication in primary lymphocyte cultures (Gibbs et aI., 1994; Park et al., 1994) . HIV-1 genomes with v/f mutations also are restricted for replication in primary T lymphocytes (Gabuzda et at., 1994) . This finding indicates that Vif is likely to be essential for infection of lymphocytes and perhaps other cell types in the susceptible host.
Both v/f mutants SIVmac239-2S, containing stop codons at the N terminus (nt 5670), and SIVmac239-2C, containing stop codons at the C terminus (nt 6010), were not able to replicate in the H9 cell line (Fig. 3a) ; this finding indicates that sequences near both the N terminus and the C terminus of Vif are essential for its function. Further studies are required to determine the precise step(s) in viral replication governed by Vif and to define a functional domain(s) in this viral protein.
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